SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-060543
Filing Date
2020-11-25
Accepted
2020-11-25 17:03:32
Documents
1
Period of Report
2020-11-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3732
  Complete submission text file 0001209191-20-060543.txt   5144
Mailing Address 230 PARK AVENUE, SUITE 2800 NEW YORK NY 10169
Business Address
Harrison Seth Loring (Reporting) CIK: 0001404955 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38938 | Film No.: 201351616

Mailing Address 3 PRESTON COURT BEDFORD MA 01730
Business Address 3 PRESTON COURT BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Issuer) CIK: 0001623526 (see all company filings)

IRS No.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations